Cargando…

Opticin: a potent anti-angiogenic/antiproliferative agent for breast cancer therapy

Detalles Bibliográficos
Autores principales:	Sneddon, SF, Telfer, BA, Williams, KJ, Bishop, PN, Stratford, IJ, Cowen, RL
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2875615/ http://dx.doi.org/10.1186/bcr2550

Ejemplares similares

Opticin Exerts Its Anti-angiogenic Activity by Regulating Extracellular Matrix Adhesiveness
por: Le Goff, Magali M., et al.
Publicado: (2012)

Intravitreal Pharmacokinetic Study of the Antiangiogenic Glycoprotein Opticin
por: del Amo, Eva M., et al.
Publicado: (2020)

In vivo effect of opticin deficiency in cartilage in a surgically induced mouse model of osteoarthritis
por: Farrán, Aina, et al.
Publicado: (2018)

Intravitreal administration of recombinant human opticin protects against hyperoxia-induced pre-retinal neovascularization
por: Klaska, Izabela P., et al.
Publicado: (2022)

Evaluation of the anti-angiogenic action of melatonin in breast cancer
por: Jardim, Bruna V, et al.
Publicado: (2013)

Superinfection by discordant subtypes of HIV-1 does not enhance the neutralizing antibody response against autologous virus
por: Mayr, LM, et al.
Publicado: (2012)

Opticin, a small leucine-rich proteoglycan, is uniquely expressed and translocated to the nucleus of chronic lymphocytic leukemia cells
por: Mikaelsson, Eva, et al.
Publicado: (2013)

Complement Factor H, Vitronectin, and Opticin Are Tyrosine-Sulfated Proteins of the Retinal Pigment Epithelium
por: Kanan, Yogita, et al.
Publicado: (2014)

Design and Synthesis of Novel Dehydroepiandrosterone Analogues as Potent Antiproliferative Agents
por: Huang, Xing, et al.
Publicado: (2018)

Gold(I/III)-Phosphine Complexes as Potent Antiproliferative Agents
por: Kim, Jong Hyun, et al.
Publicado: (2019)

Elevated soluble Flt1 mediates an anti-angiogenic state in patients with ANCA-associated vasculitis
por: Le Roux, S, et al.
Publicado: (2010)

Recognition and penetration of the HIV-1 Env glycan shield by potent broadly neutralizing antibodies
por: Julien, J, et al.
Publicado: (2012)

P-089: EVALUATION OF SAFETY AND EFFICACY OF HBS-SAILIN®: A POTENT INGENIOUS ANTI-SICKLING AGENT THAT REDUCES PAIN AND IMPROVES THE QUALITY OF LIFE IN SICKLE CELL PATIENTS.
por: S., BHATT, et al.
Publicado: (2022)

Alphalinolenic acid, a potent inhibitor of fatty acid synthase antimycobacterial agent
por: Jainu, Mallika, et al.
Publicado: (2014)

Evaluation of the expression of angiogenic factors in breast cancer after curcumin treatment
por: Ferreira, Lívia C, et al.
Publicado: (2013)

An interplay of microglia and matrix metalloproteinase MMP9 under hypoxic stress regulates the opticin expression in retina
por: Patnaik, Satish, et al.
Publicado: (2021)

Use of textural analysis of tumour vascular heterogeneity as a biomarker of response to anti-angiogenic treatment in patients with nasopharyngeal carcinoma
por: Teo, Qiao Qi, et al.
Publicado: (2014)

BUL: a novel lectin from Bauhinia ungulataL. seeds with fungistatic and antiproliferative activities
por: Silva, André, et al.
Publicado: (2014)

ZD6474 in combination with paclitaxel and UVB irradiation enhances the antiproliferative effect and apoptosis on breast carcinoma
por: Sarkar, S, et al.
Publicado: (2009)

Design, Synthesis, and Biological Evaluation of Artemisinin-Indoloquinoline Hybrids as Potent Antiproliferative Agents
por: Wang, Li, et al.
Publicado: (2014)

Highly potent VEGF-A-antagonistic DARPins as anti-angiogenic agents for topical and intravitreal applications
por: Stahl, Andreas, et al.
Publicado: (2012)

AZD9773 is a novel and potent anti-TNFα polyclonal ovine immune Fab
por: Newham, P, et al.
Publicado: (2011)

Design and Synthesis of C-19 Isosteviol Derivatives as Potent and Highly Selective Antiproliferative Agents
por: Luan, Tian, et al.
Publicado: (2018)

Potent inhibition of nitroglycerin bioactivation by diphenyleneiodonium (DIP)
por: Neubauer, Regina, et al.
Publicado: (2013)

Imaging the breast following neoadjuvant chemotherapy: does improvement of imaging findings in the axilla predict pathological response in the breast?
por: Williams, A, et al.
Publicado: (2012)

Neutrophils from renal cell carcinoma patients show increased expression of immunosuppressive and angiogenic gene profile
por: Obery, Dana R, et al.
Publicado: (2013)

In silico docking studies for designing potent anti-diabetic derivatives of swertiamarin with enzyme HMG COA reductase
por: Bhatt, Jayshil, et al.
Publicado: (2014)

Induction of potent systemic anti-melanoma immunity through intratumoral CD40 activation and checkpoint blockade
por: Singh, Manisha, et al.
Publicado: (2015)

P04-14. Sequential HIV-1 isolates from infected individuals reveals emergence of neutralization sensitive HIV-1 strains in the course of infection
por: Nyambi, PN, et al.
Publicado: (2009)

P05-12. A computationally designed immunogen elicits potent anti-V3 neutralizing antibodies
por: Carrico, CT, et al.
Publicado: (2009)

Ghrelin: an anti-inflammatory theurapeutic agent in septic rats
por: Uluçay, GA, et al.
Publicado: (2014)

Using angiogenic factors and their soluble receptors to predict organ dysfunction in patients with disseminated intravascular coagulation associated with severe trauma
por: Wada, T, et al.
Publicado: (2012)

Synthesis and Biological Evaluation of Novel Phosphatidylcholine Analogues Containing Monoterpene Acids as Potent Antiproliferative Agents
por: Gliszczyńska, Anna, et al.
Publicado: (2016)

Masked Phenolic-Selenium Conjugates: Potent and Selective Antiproliferative Agents Overcoming P-gp Resistance
por: Begines, Paloma, et al.
Publicado: (2020)

AB110. In vitro evaluation of endothelial progenitor cells from adipose tissue as potential angiogenic cell sources for bladder angiogenesis
por: Zhou, Liuhua, et al.
Publicado: (2016)

Anti-HER2 imaging agents for breast cancer imaging
por: Tolner, B, et al.
Publicado: (2010)

Systemic delivery of liposome-anchored anti-CD137 and IL2-Fc prevents lethal toxicity and elicits potent antitumor immunity
por: Zhang, Yuan, et al.
Publicado: (2015)

The use of pulmonary artery catheterization has declined
por: Appavu, S, et al.
Publicado: (2005)

Analysis of opticin binding to collagen fibrils identifies a single binding site in the gap region and a high specificity towards thin heterotypic fibrils containing collagens II, and XI or V/XI
por: Hansen, Uwe, et al.
Publicado: (2020)

Efficacy and safety of anti-TNF agents in patients with enthesitis related arthritis
por: Tynjälä, P, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_iv3cf1eb53rciauq26is21j6j8